Company · founded 1965

Charles River Associates

Boston, United States · charlesriverassociates.com

Manage this page

Citations, last 5 years: 680
Works, last 5 years: 184
h-index: 83
Scientists listed: 13
Grants since 2016: 1 402

Grants received

2024–2026 · fellowship · F31

Glycopolymer Biomaterials for Regulating Adaptive Reprogramming in Glia

Eric Dubois · Charles River Associates · funded by National Institutes of Health

$40.9kNeurogenesis and neuroplasticity mechanisms

2024–2028 · research · R01

Hip structure and function in young female athletes

Cara L Lewis · Charles River Associates · funded by National Institutes of Health

$165k

2024–2029 · career development · K23

Dual language input, semantic structure and word learning in typically developing and late talking bilingual children

Kimberly Crespo · Charles River Associates · funded by National Institutes of Health

$193.8kLanguage Development and Disorders

2024–2026 · research · R21

Nanotherapeutics for Targeted Glial Cell Drug Delivery

Timothy Mark O'Shea · Charles River Associates · funded by National Institutes of Health

$247.5k

2024–2027 · research · R21

Injectable Optoacoustic Retina Prostheses

Chen Yang · Charles River Associates · funded by National Institutes of Health

$588.6kNeuroscience and Neural Engineering

2024–2029 · research · R01

Investigating the Effect of Arousal on Visual Processing

Janneke Jehee · Charles River Associates · funded by National Institutes of Health

$363.4k

2024–2026 · fellowship · F31

Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Amber Normann · Charles River Associates · funded by National Institutes of Health

$38.6k

2024–2026 · fellowship · F99

Genetic and Neural Sources of Individual Differences in Goal-directed Learning in Health and Disease

Alanna Carey · Charles River Associates · funded by National Institutes of Health

$49.6k

2024–2026 · research · R21

Transcranial stimulation combined with auditory training

Elin Roverud · Charles River Associates · funded by National Institutes of Health

$443.7kHearing Loss and Rehabilitation

2024–2025 · fellowship · F31

Neural Circuit Dynamics Underlying Perceptual Decision Making in the Macaque Dorsolateral Prefrontal Cortex

Eric Kenji Lee · Charles River Associates · funded by National Institutes of Health

$38.4k

2024–2026 · fellowship · F31

Development of a Tunable Protein Release Hydrogel for the Enhancement of CAR T cell Activity

Sarah C Adams · Charles River Associates · funded by National Institutes of Health

$41.4kCAR-T cell therapy research

2024–2029 · training · T32

Graduate Training at the Interface of Neuroscience, Optical Engineering and Data Science

David A Boas · Charles River Associates · funded by National Institutes of Health

$167.4k

2024–2027 · fellowship · F32

Thalamocortical Circuits Governing Egocentric-Allocentric Spatial Reference Frame Transformations

Patrick Adam Lachance · Charles River Associates · funded by National Institutes of Health

$74.3kMemory and Neural Mechanisms

2024–2029 · research · R01

A Relaxin-loaded Hydrogel for the Treatment of Hypertrophic Scars

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$526kPregnancy-related medical research

2024–2027 · research · RF1

Reelin and Receptor Splicing in Alzheimer's Disease

Uwe Beffert · Charles River Associates · funded by National Institutes of Health

$2.4MNeurogenesis and neuroplasticity mechanisms

2024–2027 · fellowship · F31

Examining Sex-Specific Effects on White Matter Integrity and Brain Function in Familial Alzheimer's Disease and Vascular Dementia

Averi Jordin Giudicessi · Charles River Associates · funded by National Institutes of Health

$49kDementia and Cognitive Impairment Research

2024–2026 · career development · K99

Uncovering the Molecular Determinants of Cell Type-Specific Connectivity

Maria Victoria Moya · Charles River Associates · funded by National Institutes of Health

$126.4k

2024–2025 · fellowship · F32

Longitudinal trajectories of white matter and reading development in bilingual children

Juliana Ronderos · Charles River Associates · funded by National Institutes of Health

$80.8kReading and Literacy Development

2024–2029 · research · R35

Regulating parenchymal repair in wound healing

Timothy Mark O'Shea · Charles River Associates · funded by National Institutes of Health

$412.5kWound Healing and Treatments

2024–2026 · research · R03

Multimodal Characterization of Cerebral Reorganization in Children with Unilateral Cerebral Palsy

Claudio Luis Ferre · Charles River Associates · funded by National Institutes of Health

$330kCerebral Palsy and Movement Disorders

2024–2025 · fellowship · F31

Bilingualism as a cognitive reserve factor: the behavioral and neural underpinnings of cognitive control in bilingual patients with aphasia

Erin Carpenter · Charles River Associates · funded by National Institutes of Health

$37.3kNeurobiology of Language and Bilingualism

2024–2027 · research · R33

Bio-orthogonal Mid-Infrared Photothermal Imaging of Cancer Metabolism

Ji-Xin Cheng · Charles River Associates · funded by National Institutes of Health

$407.1k

2024–2027 · fellowship · F31

Development and characterization of self-amplifying RNA Lipid Nanoparticles for potent and multiplex gene expression in solid tumors

Arun Kannoth Nambiar · Charles River Associates · funded by National Institutes of Health

$40.7kRNA Interference and Gene Delivery

2024–2027 · research · R21

Telehealth Exercise and Mindfulness of Pain in knee Osteoarthritis (TEMPO): A digital Feasibility Study

Deepak Kumar · Charles River Associates · funded by National Institutes of Health

$299.8k

2024–2029 · fellowship · F30

A Bio-orthogonal Targeting System for Precision Drug Delivery to Vascular Endothelium in Transplanted Organs

Aria Pearlman Morales · Charles River Associates · funded by National Institutes of Health

$54k

2024–2026 · cooperative agreement · UG3

Expanding Inclusion of All Subjects for Ultra-High Density Wearable fNIRS in the Everyday World

David A Boas · Charles River Associates · funded by National Institutes of Health

$422.6k

2024–2029 · research · R01

Primate inhibitory neurons in hippocampal CA3-CA1 intrinsic circuits

Helen Barbas · Charles River Associates · funded by National Institutes of Health

$825k

2024–2027 · research · R01

Extending Reach, Accuracy, and Therapeutic Capabilities: A Soft Robot for Peripheral Early-Stage Lung Cancer

Sheila Russo · Charles River Associates · funded by National Institutes of Health

$22.4kSoft Robotics and Applications

2024–2028 · research · R01

Engineering recombinase circuits for cellular diagnostic devices

Wilson Wong · Charles River Associates · funded by National Institutes of Health

$478.5k

2024–2026 · research · R21

Studying astrocyte borders using injectable biomaterials

Timothy Mark O'Shea · Charles River Associates · funded by National Institutes of Health

$446.1k

2024–2027 · fellowship · F31

The Lombard effect in muscle tension dysphonia: mechanistic and clinical characterization

Allison Aaron · Charles River Associates · funded by National Institutes of Health

$39.4kVoice and Speech Disorders

2024 · research · R21

New detection paradigms for laser-scanning microscopy leveraging fiber optical amplifiers

Jeffrey Dakin Demas · Charles River Associates · funded by National Institutes of Health

$19.3kOptical Coherence Tomography Applications

2024–2026 · research · R21

Identifying and Addressing Barriers in the Cervical Cancer Treatment Cascade among Women with HIV in South Africa

Christina Psaros · Charles River Associates · funded by National Institutes of Health

$368.1kCervical Cancer and HPV Research

2024–2025 · fellowship · F31

Assessment of real-time reading comprehension in bilinguals with aphasia

Michael David Scimeca · Charles River Associates · funded by National Institutes of Health

$38.6kNeurobiology of Language and Bilingualism

2024–2029 · research · R01

Lysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$642.7k

2024–2027 · research · R01

Super-sensitive vibrational imaging by synergic development of instruments and probes

Daniela Buccella · Charles River Associates · funded by National Institutes of Health

$556.3kSpectroscopy Techniques in Biomedical and Chemical Research

2024–2026 · research · R21

Exploring the Rescue Strategy for Female NEXMIF Haploinsufficiency via X Chromosome Reactivation

Hengye Man · Charles River Associates · funded by National Institutes of Health

$445.2kGenetics and Neurodevelopmental Disorders

2024–2026 · fellowship · F32

Speech, Language, and Motor Skills in Late Talkers

Marc Maffei · Charles River Associates · funded by National Institutes of Health

$81.3kLanguage Development and Disorders

2024–2027 · fellowship · F32

Thalamocortical Circuits Governing Egocentric-Allocentric Spatial Reference Frame Transformations

Patrick Adam Lachance · Charles River Associates · funded by National Institutes of Health

$78k

2024–2027 · fellowship · F31

The Lombard effect in muscle tension dysphonia: mechanistic and clinical characterization

Allison Aaron · Charles River Associates · funded by National Institutes of Health

$39.9k